Dyslipidemia and pre-eclampsia

Pre-Eclampsia: Etiology and Clinical Practice

Volumn , Issue , 2007, Pages 164-182

  Hubel, Carl A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928279333     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545634.012     Document Type: Chapter

References (116)

1. Agatisa, P., Ness, R., Roberts, J., Costantino, J., Kuller, L. and McLaughlin, M. (2004). Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am. J. Physiol., 286, 1389–93.
2. Alvarez, J. J., Montelongo, A., Iglesias, A., Lasuncion, M. A. and Herrera, E. (1996). Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J. Lipid Res., 37, 299–308.
3. Arbogast, B. W., Leeper, S. C., Merrick, R. D., Olive, K. E. and Taylor, R. N. (1996). Plasma factors that determine endothelial cell lipid toxicity in vitro correctly identify women with preeclampsia in early and late pregnancy.Hypertens. Pregn., 15, 263–79.
4. Barden, A., Ritchie, J., Walters, B., et al. (2001). Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension, 38, 803–8.
5. Barden, A. E., Beilin, L. J., Ritchie, J., Walters, B. N. and Michael, C. (1999). Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J. Hypertens., 17, 1307–15.
6. Belo, L., Caslake, M., Gaffney, D., et al. (2002). Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis, 162, 425–32.
7. Bilodeau, J.-F. and Hubel, C. (2003). Current concepts in the use of antioxidants for the treatment of preeclampsia.J. Obstet. Gynecol. Can., 25, 742–50.
8. Bonet, B., Brunzell, J. D., Gown, A. M. and Knopp, R. H. (1992). Metabolism of very-low-density lipoprotein triglyceride by human placental cells: the role of lipoprotein lipase. Metabolism, 41, 596–603.
9. Bourdon, E., Loreau, N. and Blache, D. (1999). Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J., 13, 233–44.
10. Branch, D. W., Mitchell, M. D., Miller, E., Palinski, W. and Witztum, J. L. (1994). Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet, 343, 645–6.
11. Catalano, P., Tyzbir, E., Roman, N., Amini, S. and Sims, E. (1991). Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am. J. Obstet. Gynecol., 165, 1667–72.
12. Chambers, J., Fusi, L., Malik, I., Haskard, D., De Swiet, M. and Kooner, J. (2001). Association of maternal endothelial dysfunction with preeclampsia. J. Am. Med. Ass., 285, 1607–12.
13. Chappell, L., Seed, P., Briley, A., et al. (2002). A longitudinal study of biochemical variables in women at risk of pre-eclampsia. Am. J. Obstet. Gynecol., 187, 127–36.
14. Chesley, L. C. (1978). Eclampsia: the remote prognosis.Semin. Perinatol., 2, 99–111.
15. Clausen, T., Djurovic, S. and Henriksen, T. (2001). Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia.Br. J. Obstet. Gynaecol., 108, 1081–7.
16. Coleman, R. A. (1989). The role of the placenta in lipid metabolism and transport. Semin. Perinatol., 13, 180–91.
17. Davda, R., Stepniakowski, K. T., Lu, G., Ullian, M. E., Goodfriend, T. L. and Egan, B. M. (1995). Oleic acid inhibits nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension, 26, 764–70.
18. Dewolf, F., Robertson, W. B. and Brosens, I. (1975). The ultrastructure of acute atherosis in hypertensive pregnancy. Am. J. Obstet. Gynecol., 123(2), 164–74.
19. Elzen, H. v. d., Waldimiroff, J., Cohen-Overbeek, T., Bruijn, A. d. and Grobbee, D. (1996). Serum lipids in early pregnancy and risk of preeclampsia. Br. J. Obstet. Gynaecol., 103, 117–22.
20. Endresen, M. J., Lorentzen, B. and Henriksen, T. (1992). Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am. J. Obstet. Gynecol., 167, 440–7.
21. Endresen, M. J., Tosti, E., Heimli, H., Lorentzen, B. and Henriksen, T. (1994). Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand. J. Clin. Lab. Invest., 54, 549–57.
22. Fisher, K. A., Lluger, A., Spargo, B. H. and Lindheimer, M. D. (1981). Hypertension in pregnancy: clinical–pathological correlations and remote prognosis.Medicine, 60, 267–76.
23. Fukumura, D., Ushiyama, A., Duda, D., et al. (2003). Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ. Res., 93, e88–e97.
24. Gardner, C. D., Fortmann, S. P. and Krauss, R. M. (1996). Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Ass., 276, 875–81.
25. Gratacos, E., Casals, E., Sanllehy, C., Cararach, V., Alonso, P. L. and Fortuny, A. (1996). Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet. Gynecol. Scand., 75, 896–901.
26. Gratacos, E., Casals, E., Gomez, O., et al. (2003). Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia. Br. J. Obstet. Gynaecol., 110, 400–4.
27. Gregory, K., Kjos, S. and Peters, R. (1993). Cost of non-insulin-dependent diabetes in women with a history of gestational diabetes: implications for prevention.Obstet. Gynecol., 81, 782–6.
28. Griendling, K. K., Sorescu, D. and Ushio-Fukai, M. (2000). NAD(P)H oxidase – role in cardiovascular biology and disease. Circ. Res., 86, 494–501.
29. Hannaford, P., Ferry, S. and Hirsch, S. (1997). Cardiovascular sequelae of toxaemia of pregnancy. Heart, 77, 154–8.
30. He, S., Silveira, A., Hamsten, A., Blomback, M. and Bremme, K. (1999). Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb. Haemost., 81, 538–42.
31. Henriksen, T. (2000). The role of lipid oxidation and oxidative lipid derivatives in the development of preeclampsia. Semin. Perinatol., 24, 29–32.
32. Herrera, E. (2002). Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine, 19, 43–55.
33. Herrera, G., Lasuncion, M. A., Coronado, D. G., Aranda, P., Lona, P. L. and Maier, I. (1988). Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am. J. Obstet. Gynecol., 158, 1575–83.
34. Hill, J., Zalos, G., Hacox, J., et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med., 348, 593–600.
35. Hubel, C. (1999). Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med., 222, 222–35.
36. Hubel, C. A. (1998). Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin. Reprod. Endocrinol., 16, 75–92.
37. Hubel, C. A. and Roberts, J. M. (1999). Lipid metabolism and oxidative stress. In Chesley’s Hypertensive Disorders in Pregnancy, ed. M. D. Lindheimer, J. M. Roberts and F. G. Cunningham. Stamford, CT: Appleton & Lange, pp. 453–86.
38. Hubel, C. A., McLaughlin, M. K., Evans, R. W., Hauth, B. A., Sims, C. J. and Roberts, J. M. (1996). Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am. J. Obstet. Gynecol., 174, 975–82.
39. Hubel, C. A., Lyall, F., Weissfeld, L., Gandley, R. E. and Roberts, J. M. (1998a). Small low-density lipoproteins and vascular cell adhesion molecule (VCAM-1) are increased in association with hyperlipidemia in preeclampsia.Metabolism, 47, 1281–8.
40. Hubel, C. A., Shakir, Y., Gallaher, M. J., McLaughlin, M. K. and Roberts, J. M. (1998b). Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increases. J. Soc. Gynecol. Invest., 5, 244–50.
41. Hubel, C. A., Roberts, J. M. and Ferrell, R. E. (1999). Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.Clin. Genet., 56, 289–96.
42. Hubel, C. A., Snaedal, S., Ness, R. B., et al. (2000). Dyslipoproteinemia in postmenopausal women with a history of eclampsia. Br. J. Obstet. Gynaecol., 107, 776–84.
43. Jonsdottir, L. S., Arngrimsson, R., Geirsson, R. T., Sigvaldason, H. and Sigfusson, N. (1995). Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet. Gynecol. Scand., 74, 772–6.
44. Kaaja, R. (1998). Insulin resistance syndrome in preeclampsia.Semin. Reprod. Endocrinol., 16, 41–6.
45. Kaaja, R., Tikkanen, M. J., Viinikka, L. and Ylikorkala, O. (1995). Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet. Gynecol., 85, 353–6.
46. Kaaja, R., Laivuori, H., Laakso, M., Tikkanen, M. J. and Ylikorkala, O. (1999). Evidence of a state of increased insulin resistance in preeclampsia. Metabolism, 48, 892–6.
47. Kagan, V., Tyurin, V., Borisenko, G., et al. (2001). Mishandling of copper by albumin: role in redoxcycling and oxidative stress in preeclampsia plasma.Hypertens. Pregn., 20, 221–42.
48. Kahn, B. B. and Flier, J. S. (2000). Obesity and insulin resistance. J. Clin. Invest., 106, 473–81.
49. Kim, Y. J., Williamson, R. A., Chen, K., Smith, J. L., Murray, J. C. and Merrill, D. C. (2001). Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia.Hypertension, 38, 992–6.
50. Kirwan, J., Hauguel-Demouzon, S., Leqercq, J., et al. (2002). TNFa is a predictor of insulin resistance in human pregnancy. Diabetes, 51, 2207–13.
51. Krauss, R. M. (1991). The tangled web of coronary risk factors. Am. J. Med., 90, 2a–36s.
52. Krauss, R. M. (1997). Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype. In Genetic Variation and Dietary Response. World Rev. Nutr. Diet, vol. 80, ed. A. P. Simopoulos and P. J. Nestel. Basel: Karger, pp. 2–43.
53. Kuhl, C. (1991). Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes, 40, 18–24.
54. Laivuori, H., Tikkanen, M. J. and Ylikorkala, O. (1996). Hyperinsulinemia 17 years after preeclamptic first pregnancy. J. Clin. Endocrinol. Metab., 81, 2908–11.
55. Lamarche, B. and Lewis, G. (1998). Atherosclerosis prevention for the next decade: risk assessment beyond low density lipoprotein cholesterol. Can. J. Cardiol., 14, 841–51.
56. Lamarche, B., Tchernof, A., Moorjani, S., et al. (1997). Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men.Circulation, 95, 69–75.
57. Lamarche, B., Tchernof, A., Mauriege, P., et al. (1998). Fasting insulin and apolipoprotein B levels and lowdensity lipoprotein particle size as risk factors for ischemic heart disease. J. Am. Med. Ass., 279, 1955–61.
58. Lamarche, B., Rashid, S. and Lewis, G. F. (1999). HDL metabolism in hypertriglyceridemic states: an overview.Clin. Chim. Acta, 286, 145–61.
59. Lewis, G. F. and Steiner, G. (1996). Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulindependent diabetes mellitus. Diabetes Metab. Rev., 12, 37–56.
60. Lorentzen, B. and Henriksen, T. (1998). Plasma lipids and vascular dysfunction in preeclampsia. Semin. Reprod. Endocrinol., 16, 33–9.
61. Lorentzen, B., Endresen, M. J., Clausen, T. and Henriksen, T. (1994). Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia.Hypertens. Pregn., 13, 103–9.
62. Lorentzen, B., Drevon, C. A., Endressen, M. J. and Henriksen, T. (1995). Fatty acid pattern of esterfied and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br. J. Obstet. Gynaecol., 102, 530–7.
63. Lorentzen, B., Birkeland, K. I., Endresen, M. J. and Henriksen, T. (1998). Glucose intolerance in women with preeclampsia. Acta Obstet. Gynecol. Scand., 77, 22–7.
64. Ma, Y., Ooi, T. C., Liu, M. S., et al. (1994). High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J. Lipid. Res., 35, 1066–75.
65. Martin, U., Davies, C., Hayavi, S., Hartland, A. and Dunne, F. (1999). Is normal pregnancy atherogenic?Clin. Sci., 96, 421–5.
66. Montelongo, A., Lasuncion, M. A., Pallardo, L. F. and Herrera, E. (1992). Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes, 41, 1651–9.
67. Montes, A., Walden, C. E., Knopp, R. H., Cheung, M., Chapman, M. B. and Albers, J. J. (1984). Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Possible markers for the diagnosis of “prelipemia”.Arteriosclerosis, 4, 407–17.
68. Murai, J. T., Muzykanskiy, E. and Taylor, R. N. (1997). Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia.Metabolism, 46, 963–7.
69. Murata, M., Kodama, H., Goto, K., Hirano, H. and Tanaka, T. (1996). Decreased very-low-density lipoprotein and low-density lipoprotein receptor messenger ribonucleic acid expression in placentas from preeclamptic pregnancies. Am. J. Obstet. Gynecol., 175, 1551–6.
70. Ness, R. B. and Roberts, J. M. (1996). Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am. J. Obstet. Gynecol., 175, 1365–70.
71. Ness, R., Markovic, N., Bass, D., Harger, G. and Roberts, J. (2003). Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet. Gynecol., 102, 1366–71.
72. Nisell, H., Erikssen, C., Persson, B. and Carlstrom, K. (1999). Is carbohydrate metabolism altered among women who have undergone a preeclamptic pregnancy?Gynecol. Obstet. Invest., 48, 241–6.
73. O’Brien, S. F. O., Watts, G. F., Playford, D. A., Burke, V., O’Neal, D. N. and Best, J. D. (1997). Low-density lipoprotein size, high density lipoproteinconcentration, and endothelial dysfunction in noninsulin-dependent diabetes. Diabetic Med., 14, 974–8.
74. Ogura, K., Miyatake, T., Fukui, O., Nakamura, T., Kameda, T. and Yoshino, G. (2002). Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia.J. Atheroscler. Thromb., 9, 42–7.
75. Pleiner, J., Schaller, G., Mittermayer, F., Bayerle-Eder, M., Roden, M. and Wolzt, M. (2002). FFA-induced endothelial dysfunction can be corrected by vitamin C. J. Clin. Endocrinol. Metab., 87, 2913–17.
76. Plotnick, G. D., Corretti, M. C. and Vogel, R. A. (1997). Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. J. Am. Med. Ass., 278, 1682–6.
77. Potter, J. M. and Nestle, P. J. (1979). The hyperlipidemia of pregnancy in normal and complicated pregnancies.Am. J. Obstet. Gynecol., 133, 165–70.
78. Ramirez, R. J., Novak, J., Johnston, T. P., Gandley, R. E., McLaughlin, M. K. and Hubel, C. A. (2001). Endothelial function and myogenic reactivity in small mesenteric arteries of hyperlipidemic pregnant rats. Am. J. Physiol., 281, R1330–7.
79. Reaven, G. M. (1994). Syndrome X: 6 years later. J. Internal. Med., 236, 13–22.
80. Redman, C. W. G., Sacks, G. P. and Sargent, I. L. (1999). Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol., 180, 499–506.
81. Roberts, J. M. and Hubel, C. A. (1999). Is oxidative stress the link in the two-stage model of pre-eclampsia?Lancet, 354, 788–9.
82. Ross, R. (1999). Atherosclerosis – an inflammatory disease. N. Engl. J. Med., 340, 115–26.
83. Sacks, G. P., Studena, K., Sargent, I. I. and Redman, C. W. G. (1998). Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol., 179, 80–6.
84. Sacks, G., Sargent, I. and Redman, C. (1999). An innate view of human pregnancy. Immunol. Today, 20, 114–18.
85. Sattar, N. and Greer, I. A. (2002). Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br. Med. J., 325, 157–60.
86. Sattar, N., Bedomir, A., Berry, C., Shepherd, J., Greer, I. A. and Packard, C. J. (1997a). Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet. Gynecol., 89, 403–8.
87. Sattar, N., Greer, I. A., Louden, J., Lindsay, G., McConnell, M., Shepherd, J. and Packard, C. J. (1997b). Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J. Clin. Endocrinol. Metab., 82, 2483–91.
88. Sattar, N., Petrie, J. R. and Jaap, A. J. (1998). The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis, 138, 229–35.
89. Sattar, N., Greer, I. A., Galloway, P. J., et al. (1999). Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. J. Clin. Endocrinol. Metab., 84, 128–30.
90. Sheppard, B. L. and Bonnar, J. (1981). An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation.Br. J. Obstet. Gynaecol., 88, 695–705.
91. Sibai, B., El-Nazer, A. and Gonzalez-Ruiz, A. (1986). Severe preeclampsia–eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am. J. Obstet. Gynecol., 155, 1011–16.
92. Sibai, B. M., Ewell, M., Levine, R. J., et al. (1997). Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am. J. Obstet. Gynecol., 177, 1003–10.
93. Silliman, K., Shore, V. and Forte, T. M. (1994). Hypertriglyceridemia during late pregnancy is associated with the formation of small dense low-density lipoproteins and the presence of large buoyant high-density lipoproteins.Metabolism, 43, 1035–41.
94. Sivan, E., Homko, C. J., Whittaker, P. G., Reece, E. A., Chen, X. and Boden, G. (1998). Free fatty acids and insulin resistance during pregnancy. J. Clin. Endocrinol. Metab., 83, 2338–42.
95. Solomon, C., Carroll, J., Okamura, K., Graves, S. and Seeley, E. (1999). Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am. J. Hypertens., 12, 276–82.
96. Solomon, C. G., Graves, S. W., Greene, M. F. and Seely, E. W. (1994). Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension, 23, 717–21.
97. Sowers, J. R., Saleh, A. A. and Sokol, R. J. (1995). Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans. Am. J. Hypertens., 8, 1–4.
98. Staff, A. C., Halvorsen, B., Ranheim, T. and Henriksen, T. (1999a). Free 8-iso-prostaglandin F2a is elevated in decidua basalis in women with preeclampsia. Am. J. Obstet. Gynecol., 181, 1211–15.
99. Staff, A. C., Ranheim, T., Khoury, J. and Henriksen, T. (1999b). Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am. J. Obstet. Gynecol., 180, 587–92.
100. Stampfer, M. J., Krauss, R. M., Ma, J., et al. (1996). A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. J. Am. Med. Ass., 276, 882–8.
101. Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G. and Baron, A. D. (1996). Obesity/insulin resistance is associated with endothelial dysfunction.J. Clin. Invest., 97, 2601–10.
102. Steinberg, H. O., Paradisi, G., Hook, G., Crowder, K., Cronin, J. and Baron, A. D. (2000). Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes, 49, 1231–8.
103. Steinberg, H. O., Tarshoby, M., Monestel, R., et al. (1997). Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J. Clin. Invest., 100, 1230–9.
104. Vigne, J. L., Murai, J. T., Arbogast, B. W., Jia, W., Fisher, S. J. and Taylor, R. N. (1997). Elevated nonesterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin. J. Clin. Endocrinol. Metab., 82, 3786–92.
105. Vogel, R. A., Corretti, M. C. and Plotnick, G. D. (1997). Effect of a single high-fat meal on endothelial function in healthy subjects. Am. J. Cardiol., 79, 350–4.
106. Wakatsuki, A., Ikenoue, N., Okatani, Y., Shinohara, K. and Fukaya, T. (2000). Lipoprotein particles in preeclampsia: susceptibility to oxidative modification.Obstet. Gynecol., 96, 55–9.
107. Walsh, S. W. (1998). Maternal–placental interactions of oxidative stress and antioxidants in preeclampsia.Semin. Reprod. Endocrinol., 16, 93–104.
108. Williams, C. and Coltart, T. M. (1978). Adipose tissue metabolism in pregnancy: the lipolytic effect of human placental lactogen. Br. J. Obstet. Gynaecol., 85, 43–6.
109. Williams, M., Zingheim, R., King, I. and Zebelman, A. (1995). Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology, 6, 232–7.
110. Winkler, K., Wetzka, B., Hoffmann, M. M., et al. (2000). Low density lipoprotein (LDL) subfractions during pregnancy: accumulation of buoyant LDL with advancing gestation. J. Clin. Endocrinol. Metab., 85, 4543–50.
111. Winkler, K., Wetzka, B., Hoffmann, M. M., et al. (2003). Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J. Clin. Endocrinol. Metab., 88, 1162–6.
112. Wittmaack, F., Gafvels, M., Bronner, M., et al. (1995). Localization and regulation of the human very low density lipoprotein/apolipoprotein-E receptor: trophoblast expression predicts a role for the receptor in placental lipid transport. Endocrinology, 136, 340–8.
113. Wolf, M., Kettyle, E., Sandler, L., Ecker, J. L., Roberts, J. and Thadhani, R. (2001). Obesity and preeclampsia: the potential role of inflammation. Obstet. Gynecol., 98, 757–62.
114. Wolf, M., Sandler, L., Munoz, K., Hsu, K., Ecker, J. and Thadhani, R. (2002). First trimester insulin resistance and subsequent preeclampsia: a prospective study.J. Clin. Endocrinol. Metab., 87, 1563–8.
115. Yuan, H., Antholine, W. E., Subczynski, W. K. and Green, M. A. (1996). Release of CuPTSM from human serum albumin after addition of fatty acids. J. Inorg. Biochem., 61, 251–9.
116. Zhang, C., Austin, M., Edwards, K., et al. (2006). Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women. Clin. Genet., 69, 33–9.